---
title: "INTERCEPT PHARMA EUROPE LTD. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8ed8466c-735d-52e1-a657-ab42f7ceecb9
json: https://whiteintel.dev/api/public/dossier/8ed8466c-735d-52e1-a657-ab42f7ceecb9
identifier: oo:GB-COH-09224395
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# INTERCEPT PHARMA EUROPE LTD.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09224395`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8ed8466c-735d-52e1-a657-ab42f7ceecb9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8ed8466c-735d-52e1-a657-ab42f7ceecb9  

## Ownership & control

### Owners / controllers

- **Intercept Pharmaceuticals, Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b813d03e-006f-450c-9750-57b4143e76cb

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09224395`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2014-09-18
- **Registered office:** C/O Emma Cray, One Chamberlain Square, Birmingham, West Midlands, B3 3AX
- **SIC:** 46460

### Officers

- ROSENBERG, Thomas — director · American · appointed 2024-11-18
- VENEZIA, Rocco — director · American · appointed 2021-03-17
- HOOD, Daniel Carey Cazel — secretary · appointed 2016-09-28 · resigned 2020-07-03
- YOON, Bryan — secretary · appointed 2014-09-18 · resigned 2017-12-04
- [QUAYSECO LIMITED](https://whiteintel.dev/entity/d99f4fa0-3ee0-5fa7-9265-4026a63b42f5) — corporate secretary · appointed 2015-08-19 · resigned 2025-03-18
- ADEKUNLE, Olufemi Abimbola, Dr — director · British · appointed 2021-10-19 · resigned 2022-07-01
- ARNOLD, Stephen — director · British · appointed 2020-09-30 · resigned 2021-02-26
- BRIGHT, Lisa Jane — director · British · appointed 2016-09-28 · resigned 2020-09-30
- CAREY, Robert James — director · British · appointed 2020-09-30 · resigned 2021-01-07
- DUNCAN, Barbara Gayle — director · American · appointed 2014-09-18 · resigned 2016-09-28
- FORD, David — director · American,British,New Zealander · appointed 2023-01-24 · resigned 2023-11-21
- GEMELLARO, Michael — director · American · appointed 2021-06-28 · resigned 2023-01-24
- HIGSON, Graham Charles — director · British · appointed 2023-01-24 · resigned 2024-04-27
- HOOD, Daniel Carey Cazel — director · British · appointed 2019-09-05 · resigned 2020-07-03
- KAPADIA, Sandip — director · Indian · appointed 2016-09-28 · resigned 2021-03-26
- KENYON, Stephanie Rose — director · British · appointed 2023-01-24 · resigned 2023-11-23
- MUNSTER, Kathleen — director · American · appointed 2023-01-24 · resigned 2024-07-24
- PRUZANSKI, Mark, Dr — director · Canadian · appointed 2015-08-19 · resigned 2021-01-01
- RICHARDSON, Linda — director · American · appointed 2021-06-28 · resigned 2023-01-24
- STOCKWELL, Caroline Amelia — director · British · appointed 2020-12-09 · resigned 2021-10-29

### Beneficial owners (Persons with Significant Control)

- [Intercept Pharmaceuticals, Inc.](https://whiteintel.dev/entity/b813d03e-006f-450c-9750-57b4143e76cb) — 75–100% shares · corporate PSC · United States — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09224395

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **INTERCEPT PHARMA EUROPE LTD.** — https://whiteintel.dev/entity/8ed8466c-735d-52e1-a657-ab42f7ceecb9 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **INTERCEPT PHARMA EUROPE LTD.**. Human view: https://whiteintel.dev/entity/8ed8466c-735d-52e1-a657-ab42f7ceecb9 · Structured JSON: https://whiteintel.dev/api/public/dossier/8ed8466c-735d-52e1-a657-ab42f7ceecb9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._